BridgeBio Comes Back With Positive Phase III Results For Acoramidis In ATTR-CM

 
• By Alaric DeArment
  
BridgeBio announced data from its Phase III trial of acoramidis in ATTR-CM • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D